文献速递骨肌神经CTMR

脊柱脊索瘤与良性脊索细胞瘤的影像-病理对照

Imaging of spinal chordoma and benign notochordal cell tumor (BNCT) with radiologic pathologic correlation.
PubMed 文献 · Skeletal Radiol · 2022-09-05

本文综述良性脊索细胞瘤(BNCT)与脊柱脊索瘤的临床、病理及影像特征。BNCT常为偶然发现,CT示斑片状硬化,T1WI骨髓替代、T2WI高信号,多小于35mm,无强化或骨破坏;脊索瘤为局部侵袭性低度恶性肿瘤,CT常见钙化(50-70%),MR呈多分叶T2高信号,完全切除率低(21-75%),局部复发率高(19-75%)。

要点

  • BNCT通常小于35mm,无骨破坏、皮质渗透或软组织肿块,多无需活检。
  • 脊索瘤CT钙化率50-70%,MR多分叶T2高信号反映黏液成分和出血。
  • 脊索瘤完全切除率21-75%,局部复发率19-75%,5年生存率45-86%。

核心结论

  • BNCT为良性脊索残余,影像多偶然发现、无侵袭征象,通常无需活检或切除,可影像随访。
  • 脊索瘤为局部侵袭性低度恶性肿瘤,诊断时常较大,治疗以手术为主,预后与切除范围相关。

研究设计与样本

  • 本文为综述,纳入文献范围未明确报告检索策略与样本量。
  • BNCT在尸检标本中占19%,脊索瘤占原发恶性骨肿瘤的1-4%。

关键影像表现/征象

  • BNCT CT常见斑片状硬化,位于保留的骨小梁之间;MR T1WI示骨髓替代,T2WI高信号。
  • 脊索瘤CT示骨破坏与硬化混合、钙化(50-70%)及较大软组织成分;MR T1WI多分叶骨髓替代、T2WI高信号。

诊断标准与关键数值

  • BNCT常小于35mm,缺乏明显强化、骨破坏、皮质渗透或软组织成分。
  • 脊索瘤CT钙化率50-70%,完全切除率21-75%,局部复发率19-75%,5年生存率45-86%。

临床应用与阅片要点

  • 发现脊柱偶然病变时,若小于35mm、无骨破坏或软组织肿块,应考虑BNCT而非脊索瘤。
  • 脊索瘤诊断时多较大,需仔细评估骨破坏、钙化及软组织范围以指导手术规划。
  • BNCT通常无需活检,但影像随访可能适用;脊索瘤需组织学确诊。

局限性

  • 本文为综述,未报告系统检索策略、纳入文献数量及证据分级。
  • BNCT尸检患病率19%来自特定标本,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Benign notochordal cell tumor (BNCT) and chordoma are neoplasms of notochordal differentiation. BNCT represents notochordal rests, commonly an incidental lesion present in the spine in 19% of cadaveric specimens. BNCTs are often radiographically occult. CT of BNCT frequently reveals patchy sclerosis between areas of maintained underlying trabeculae. BNCT demonstrates marrow replacement on T1-weighted MR images with high signal intensity on T2-weighting. BNCTs are frequently smaller than 35 mm and lack significant enhancement, bone destruction, cortical permeation, or soft tissue components. Biopsy or surgical resection of BNCT is usually not warranted, although imaging surveillance may be indicated. Chordoma is a rare low-grade locally aggressive malignancy representing 1-4% of primary malignant bone tumors. Chordoma is most frequent between the ages of 50-60 years with a male predilection. Clinical symptoms, while nonspecific and location dependent, include back pain, numbness, myelopathy, and bowel/bladder incontinence. Unfortunately, lesions are often large at presentation owing to diagnosis delay. Imaging of chordoma shows variable mixtures of bone destruction and sclerosis, calcification (50-70% at CT) and large soft tissue components. MR imaging of chordoma reveals multilobulated areas of marrow replacement on T1-weighting and high signal intensity on T2-weighting reflecting the myxoid component within the lesion and areas of hemorrhage seen histologically. Treatment of chordoma is primarily surgical with prognosis related to resection extent. Unfortunately, complete resection is often not possible (21-75%) resulting in high local recurrence incidence (19-75%) and a 5-year survival rate of 45-86%. This article reviews and illustrates the clinical characteristics, pathologic features, imaging appearance spectrum, treatment, and prognosis of BNCT and spinal chordoma.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Murphey, Minn, Contreras, et al. Imaging of spinal chordoma and benign notochordal cell tumor (BNCT) with radiologic pathologic correlation. Skeletal Radiol. 2022. PMID: 36063190. doi:10.1007/s00256-022-04158-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。